The Latest from Rebecca Szkutak
Canada's seed market is heading up and to the right, which is not something that can be said about the U.S.
Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This week, Natasha was joined by TC+ reporter Rebecca Szku
The FDA on Monday announced that hearing aids and other hearing technology can now be sold over the counter, ending a system that mandated a prescription.
While the venture scene in Israel mirrors the same funding pullback as other geographies, it seems to be doing so with fewer negative outcomes.
How do employee-benefits startups fare when their corporate customers start slashing costs amid a volatile market? We're going to find out if the market continues on the track it's on.
While LPs are shying away from the U.S. Midwest, VCs are not.
Now that equity is getting increasingly expensive as investors are deploying more conservatively after last year's fever, Upper90's strategy could become more useful to founders than ever.
Last year saw a record 270 first-time funds close, which means there are almost 300 new managers who raised their fund in a bull market and are now deploying it in very different market conditions.
Who will fare better in the current venture downturn? Will it be legacy investors with years of experience and sizable portfolios to worry about or emerging managers starting with a clean slate?
Ulta is just the latest corporate venture fund. The Home Depot, Chipotle, AmerisourceBergen and Booz Allen Hamilton also announced funds this year, bringing a total of $450 million to the table.
While cash from Uncle Sam may not be top of mind for startups, SBA loans can provide low-cost capital.
There are bright spots in U.S. VC investing, one of which being the Southeast region, which is on track for its best year yet.
In the post-Roe era, some VC investors and founders believe the social definition of ESG investing should expand to incorporate pressing human rights issues such as reproductive healthcare.
As venture funding slows, founders are scrambling to extend their runways, regardless of how much cash they already have. But the startups that need the cash most are running into the most trouble.
VC firms are holding on to their checkbooks as the investment market slows to a crawl, but fund managers are taking advantage of the lull to fill up their coffers to the point of overflowing.
Will healthcare startups tap into new regulatory guidelines with the same fervor that fintech founders have over the last decade?
When Andrew Hines started Canvas Medical in 2015 he couldn’t have predicted that telehealth would go from niche to norm or that a pandemic would inspire entrepreneurs to launch a new fleet of di
Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This is our Wednesday show, where we niche down to a single to
Despite the venture capital asset class sitting on historic levels of dry powder, many investors aren’t deploying it, leaving their portfolio companies scrambling for financing. Venture funding
Ariana Thacker likes to say that science was her first love and startups were her second. Now, she gets to combine the two into a thesis for her new venture firm, Conscience VC. Thacker’s passio